We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 440

Significant Tariffs on Imported Solar Cells and Modules Until 2022
  • Bryan Cave Leighton Paisner (Bryan Cave)
  • USA
  • February 6 2018

President Trump has imposed a tariff-rate quota (TRQ) on imported solar cells and a tariff on imported solar modules, both effective February 7, 2018

International Trade Commission Issues Recommendations for Tariffs on Imported Solar PV Equipment
  • McDermott Will & Emery
  • USA
  • November 3 2017

On October 31, 2017, the US International Trade Commission (ITC) released its recommendations to impose a tariff on imported solar equipment. The

ITC Recommends Remedies in Solar Cells Section 201 Case
  • Husch Blackwell LLP
  • USA
  • November 1 2017

On October 31, 2017, the United States International Trade Commission (the “Commission”) announced its remedy recommendations for the Section 201

U.S. Solar Manufacturers and Foreign Parties Offer Trade Remedies to ITC
  • Husch Blackwell LLP
  • USA
  • October 10 2017

As we discussed in a previous post, the International Trade Commission (ITC) found that U.S. producers are being seriously injured or are threatened

ITC Votes Affirmatively on Injury on Trade Case on Crystalline Silicon Photovoltaic Cells and Modules
  • Husch Blackwell LLP
  • USA
  • September 22 2017

On September 22, 2017, the U.S. International Trade Commission (“ITC”) voted in the affirmative and found that U.S. producers are being seriously

FCC Warned Against “One Size Fits All” Approach to Wireless Siting
  • Paul Weiss
  • USA
  • March 17 2017

Local governments responding to an FCC public notice (PN) on ways in which the FCC can induce local officials to expedite the approval of wireless

Breveter le vivant : une question qui gène
  • Blake Cassels & Graydon LLP
  • Canada
  • October 27 2016

Si la Cour suprême du Canada (CSC) a déjà commenté l’épineuse question de savoir si les gènes peuvent être brevetés, aucun tribunal canadien n’a

Regulatory Enforcement Power of Ireland’s Health Products Regulatory Authority
  • A&L Goodbody
  • Ireland
  • October 25 2016

HPRA regularly carries out announced and unannounced inspections (Dawn Raids) and audits to establish and monitor industry’s compliance with relevant

USPTO Launches Patents 4 Patients
  • Foley & Lardner LLP
  • USA
  • August 2 2016

To support the National Cancer Moonshot initiative, the USPTO has launched the Patents 4 Patients program, also known as the Cancer Immunotherapy

Priority Claims Unchallenged In Prosecution Can Be Weak Links
  • Marshall Gerstein & Borun LLP
  • USA
  • July 25 2016

IPR2015-00291 decided a petition filed by Daiichi Sankyo Co. Ltd. against USPN 8,168,181 owned by Alethia Biotherapeutics, Inc. The '181 patent